Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CEPHALEX | 250MG | TABLET | Resolved | 2023-07-07 | 2024-01-12 | 197876 |
| APO-CEPHALEX | 250MG | TABLET | Resolved | 2025-03-07 | 2025-03-28 | 252145 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154753 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185480 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2024-04-12 | 2024-06-14 | 225020 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-11-10 | 2024-01-12 | 209930 |
| APO-CEPHALEX | 250MG | TABLET | Resolved | 2023-03-02 | 2023-04-14 | 185939 |
| APO-CETIRIZINE | 5MG | TABLET | Resolved | 2017-08-13 | 2018-05-31 | 19090 |
| APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-07-08 | 2020-09-01 | 119696 |
| APO-CETIRIZINE | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155311 |
| APO-CETIRIZINE | 20MG | TABLET | Resolved | 2021-10-29 | 2021-12-06 | 148496 |
| APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-12-04 | 2020-12-11 | 129598 |
| APO-CHLORTHALIDONE | 50MG | TABLET | Actual shortage | 2024-12-19 | 2025-03-07 | 246071 |
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-03-20 | 2019-01-03 | 3520 |
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-04-11 | 2018-12-20 | 6414 |
| APO-CICLOPIROX | 8% | SOLUTION | Resolved | 2018-11-14 | 2019-05-24 | 66919 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2017-07-25 | 2017-08-15 | 16853 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2018-04-02 | 2018-05-09 | 44492 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2021-12-24 | 2022-04-04 | 151883 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL TABLET 10 MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE - TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM TAB 0.5MG | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM TAB 1MG | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |